Skip to main content

. 1990 May 19;300(6735):1313–1314. doi: 10.1136/bmj.300.6735.1313-a

Somatostatin analogue treatment for malignant hypercalcaemia.

M Harrison ¹, N James ¹, K Broadley ¹, S R Bloom ¹, R Armour ¹, S Wimalawansa ¹, D Heath ¹, J Waxman ¹

PMCID: PMC1663053 PMID: 2369665

1313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Broadus A. E., Mangin M., Ikeda K., Insogna K. L., Weir E. C., Burtis W. J., Stewart A. F. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide. N Engl J Med. 1988 Sep 1;319(9):556–563. doi: 10.1056/NEJM198809013190906. [DOI] [PubMed] [Google Scholar]
Heath D. A. Hypercalcaemia in malignancy. BMJ. 1989 Jun 3;298(6686):1468–1469. doi: 10.1136/bmj.298.6686.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
Schlumberger M., Ostronoff M., Bellaiche M., Rougier P., Droz J. P., Parmentier C. 5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer. 1988 Apr 15;61(8):1492–1494. doi: 10.1002/1097-0142(19880415)61:8<1492::aid-cncr2820610803>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
Stewart A. F., Hoecker J. L., Mallette L. E., Segre G. V., Amatruda T. T., Jr, Vignery A. Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. Ann Intern Med. 1985 Jun;102(6):776–779. doi: 10.7326/0003-4819-102-6-776. [DOI] [PubMed] [Google Scholar]
Suva L. J., Winslow G. A., Wettenhall R. E., Hammonds R. G., Moseley J. M., Diefenbach-Jagger H., Rodda C. P., Kemp B. E., Rodriguez H., Chen E. Y. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987 Aug 21;237(4817):893–896. doi: 10.1126/science.3616618. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES